✦ LIBER ✦

Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Chemonaive Patients With Unresectable Malignant Pleural Mesothelioma

✍ Scribed by Tsao, Anne S.; Harun, Nusrat; Lee, J. Jack; Heymach, John; Pisters, Katherine; Hong, Waun Ki; Fujimoto, Junya; Wistuba, Ignacio

Book ID: 125448310
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 192 KB
Volume: 15
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2013.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-513 Improving pulmonary function in pa

P-513 Improving pulmonary function in patients with malignant pleural mesothelioma: Results of the phase III trial of pemetrexed + cisplatin vs. cisplatin

✍ Pistolesi, M.; Symanowski, J.; Gatzemeier, U.; Emri, S.; Conte, P.; Manegold, C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

A phase II study evaluating the cisplati

A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma

✍ Berghmans, T.; Lafitte, J.J.; Paesmans, M.; Stach, B.; Berchier, M.C.; Wackenier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Pemetrexed plus carboplatin in elderly p

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

✍ Bearz, A; Castagneto, B; Zucali, P A; Favaretto, A; Mencoboni, M; Grossi, F; Cor 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

221 A phase II trial to assess the safet

221 A phase II trial to assess the safety and immunological activity of TroVax plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma. The SKOPOS trial

✍ Lester, J.F.; Casbard, A.; Roberts, K.; Tabi, Z.; Griffiths, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A phase II study of VP-16 and cisplatin

A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma

✍ Elizabeth A. Eisenhauer; William K. Evans; Nevin Murray; Walter Kocha; Rafal Wie 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 204 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group has carried out a phase II study of VP-16 100 mg/m 2 daily x 3 and cisplatin 25 mg/m 2 daily x 3 in untreated patients with malignant mesothelioma. Twenty-seven eligible patients were entered on the trial and the majority had pleur

Phase II trial of vinorelbine and oxalip

Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma

✍ Steele, J.P.C; Shamash, J; Evans, M.T; Gower, N.H; Rudd, R.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB